Indegene has struck a deal with two investment companies that will see them take a $200 million minority stake in the healthtech company. The funding from The Carlyle Group and Brighton Park ...

metaMe Health has enlisted the aid of health tech company Indegene to launch its recently-approved prescription digital therapeutic (DTx) Regulora for irritable bowel syndrome in the US.

The Indegene IPO has had an amazing response across categories, and on its first day, it was completely booked. The retail investor part received a 1.50-time subscription, while the non ...

Lack of diversified businesses, policy uncertainty in the Donald Trump era, and the challenges of GenAI pose major risks for Sagility Ltd, Indegene Ltd, and Inventurus Knowledge Solutions Ltd ...

Indegene is a company based in Princeton, New Jersey, United States, operating in the healthtech sector. Founded in 1998, it now employs 5353 individuals. The company was established by Gaurav ...

Stock market today: Despite weakness across segments on Dalal Street, Indegene share price listed on BSE and NSE at a bumper premium. Indegene share price is listed on BSE at ₹659.70 per share ...

Indegene is looking to raise a total of Rs 1,841.76 crore via IPO including a fresh share sale of Rs 760 crore and offer for sale (OFS) of up to 2,39,32,732 equity shares. The company raised Rs ...

Indegene, a digital-first life sciences commercialization company, has opened its new centre in London. This aligns with the company’s long-term growth strategy in Europe, reiterating its commitment ...

New Delhi [India], July 11 (ANI): Indegene partnered with Microsoft on Thursday to leverage generative AI for the medical industry, the company informed the exchange in a filing. The partnership ...